StockData
Glucotrack, Inc. logo

Glucotrack, Inc. (GCTK) stock

GCTKOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.68−0.04 (-5.56%)

Close on Oct 19, 2026Market cap $3.43MP/E 0.0Yield –

Glucotrack cash

Cash and short-term investments held at the end of each period.

Glucotrack's cash was $1.12M at Jun 30, 2026. For fiscal 2025 it was $7.38M, up 31.4% from the year before. Over ten years it grew 28.3% a year on average. The highest annual figure on record is $9.89M in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.38M+31.4%
FY2024Dec 31, 2024$5.62M+25.0%
FY2023Dec 31, 2023$4.49M+94.3%
FY2022Dec 31, 2022$2.31M-62.2%
FY2021Dec 31, 2021$6.11M-38.2%
FY2020Dec 31, 2020$9.89M+1976.7%
FY2019Dec 31, 2019$476.00K+217.3%
FY2018Dec 31, 2018$150.00K+178.9%
FY2017Dec 31, 2017$53.78K-70.9%
FY2016Dec 31, 2016$184.51K-69.7%
FY2015Dec 31, 2015$608.70K-89.6%
FY2014Dec 31, 2014$5.83M+144.2%
FY2013Dec 31, 2013$2.39M+339.1%
FY2012Dec 31, 2012$543.41K-71.3%
FY2011Dec 31, 2011$1.90M+26.9%
FY2010Dec 31, 2010$1.49M+2308.8%
FY2009Dec 31, 2009$62.03K-88.2%
FY2008Dec 31, 2008$526.30K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.12M-88.2%
Q1 FY2026Mar 31, 2026$3.93M-56.8%
Q4 FY2025Dec 31, 2025$7.38M+31.4%
Q3 FY2025Sep 30, 2025$7.87M+2174.3%
Q2 FY2025Jun 30, 2025$9.56M+5909.4%
Q1 FY2025Mar 31, 2025$9.10M+507.9%
Q4 FY2024Dec 31, 2024$5.62M+25.0%
Q3 FY2024Sep 30, 2024$346.00K-95.0%
Q2 FY2024Jun 30, 2024$159.00K-98.2%
Q1 FY2024Mar 31, 2024$1.50M+49.3%
Q4 FY2023Dec 31, 2023$4.49M+94.3%
Q3 FY2023Sep 30, 2023$6.89M+112.5%
Q2 FY2023Jun 30, 2023$8.77M+125.1%
Q1 FY2023Mar 31, 2023$1.00M-79.3%
Q4 FY2022Dec 31, 2022$2.31M-62.2%
Q3 FY2022Sep 30, 2022$3.24M-54.2%
Q2 FY2022Jun 30, 2022$3.90M-51.1%
Q1 FY2022Mar 31, 2022$4.84M-46.0%
Q4 FY2021Dec 31, 2021$6.11M-38.2%
Q3 FY2021Sep 30, 2021$7.08M-34.2%
Q2 FY2021Jun 30, 2021$7.97M-31.1%
Q1 FY2021Mar 31, 2021$8.95M-28.2%
Q4 FY2020Dec 31, 2020$9.89M+1976.7%
Q3 FY2020Sep 30, 2020$10.76M+741.7%
Q2 FY2020Jun 30, 2020$11.57M+396.2%
Q1 FY2020Mar 31, 2020$12.48M+14604.0%
Q4 FY2019Dec 31, 2019$476.00K+217.3%
Q3 FY2019Sep 30, 2019$1.28M+35.8%
Q2 FY2019Jun 30, 2019$2.33M+13342.4%
Q1 FY2019Mar 31, 2019$84.86K-73.0%
Q4 FY2018Dec 31, 2018$150.00K+178.9%
Q3 FY2018Sep 30, 2018$941.87K+104.0%
Q2 FY2018Jun 30, 2018$17.35K-98.5%
Q1 FY2018Mar 31, 2018$314.39K-80.8%
Q4 FY2017Dec 31, 2017$53.78K-70.9%
Q3 FY2017Sep 30, 2017$461.71K-33.7%
Q2 FY2017Jun 30, 2017$1.13M–
Q1 FY2017Mar 31, 2017$1.64M–
Q4 FY2016Dec 31, 2016$184.51K–
Q3 FY2016Sep 30, 2016$696.16K–

More Glucotrack figures

See a number that looks wrong?